Search results
Showing 16 to 30 of 31 results for endometriosis
Our updated guideline to improve the diagnosis of endometriosis
The guideline makes new recommendations and updates existing ones on diagnosing and managing a condition that affects approximately 1.5 million women of reproductive age in the UK.
One-piece closed bags for colostomies: Late Stage Assessment
In development [GID-HTE10045] Expected publication date: TBC
In development [GID-TA11340] Expected publication date: 21 May 2025
Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain (IPG234)
Evidence-based recommendations on laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain. This involves the destruction of a small segment of ligament that carries nerve fibres within the pelvis.
View recommendations for IPG234Show all sections
Sections for IPG234
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.
programmes a clinically and cost-effective intervention for women with endometriosis? Any explanatory notes(if applicable) Why this is...
Endometriosis: diagnosis and management - surgical management - pain management post-surgery
Discontinued [GID-NG10385]
Evidence-based recommendations on vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions. This involves removing the uterus (womb), and sometimes the fallopian tubes and ovaries, through the vagina.
View recommendations for IPG774Show all sections
This quality standard covers the recognition and initial management of ovarian cancer. It describes high-quality care in priority areas for improvement.
Laparoscopic helium plasma coagulation of endometriosis (IPG54)
This guidance has been updated and replaced by NICE interventional procedure guidance 171.
Pelvic floor dysfunction: prevention and non-surgical management (NG210)
This guideline covers the prevention, assessment and non-surgical management of pelvic floor dysfunction in women aged 12 and over. It aims to raise awareness and help women to reduce their risk of pelvic floor dysfunction. For women who have pelvic floor dysfunction, the guideline recommends interventions based on their specific symptoms.
Ovarian cancer: identifying and managing familial and genetic risk (NG241)
This guideline covers assessing the familial and genetic risk of having a pathogenic variant associated with ovarian cancer in adults.
Tests in secondary care to identify people at high risk of ovarian cancer (DG31)
Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G)
This guideline covers identifying and managing menopause, including in people with premature ovarian insufficiency. It aims to improve the consistency of support and information provided to people experiencing menopause.
programmes a clinically and cost-effective intervention for women with endometriosis? NG73/1